Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Researchers decipher anti-MOG antibody construction, paving way for therapies

18

Dec 2025

Researchers decipher anti-MOG antibody construction, paving way for therapies

MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a protein in the myelin layer that surrounds the neurons in the brain. It is believed that these antibodies contribute to the destruction of this protective layer in the brain.

Researchers develop antibody to combat HCMV, a common, overlooked virus

18

Dec 2025

Researchers develop antibody to combat HCMV, a common, overlooked virus

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), a common but overlooked virus that poses serious risks to vulnerable populations, including people with compromised immune systems. According to the Centers for Disease Control and Prevention, the virus is the most infectious cause of birth defects in the United States.

Social isolation emerges as a key, independent risk factor for cognitive decline

17

Dec 2025

Social isolation emerges as a key, independent risk factor for cognitive decline

Using longitudinal data from the US Health and Retirement Study, this study applied causal inference modeling to disentangle the independent and joint effects of social isolation and loneliness on later-life cognitive function. It shows that reducing social isolation is associated with modest but meaningful protection against cognitive decline, with loneliness mediating only a small proportion of this effect.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.